ENVAFOLIMAB

UNII:	ES1M06M6QH
Formula:
Preferred Substance Name:	ENVAFOLIMAB

2102192-68-5
ANTI-PD-L1 MONOCLONAL ANTIBODY KN035
ASC22
ASC-22
ENVAFOLIMAB [INN]
ENVAFOLIMAB [WHO-DD]
IMMUNOGLOBULIN G, ANTI-(HUMAN PROGRAMMED DEATH LIGAND 1) (HUMAN-CAMELIDAE MONOCLONAL KN-035 .GAMMA.-CHAIN VARIABLE REGION FRAGMENT) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN MONOCLONAL KN-035 .GAMMA.1-CHAIN FC FRAGMENT), DIMER
IMMUNOGLOBULIN VH-H-CH2-CH3 GAMMA1 CHAIN DIMER, ANTI-(HOMO SAPIENS CD274 (PROGRAMMED DEATH LIGAND 1, PDL1, PD-L1, B7 HOMOLOG 1, B7H1)), MONOCLONAL ANTIBODYGAMMA1 HEAVY CHAIN VH-H-CH2-CH3 (1-360) (VH (VICUGNA PACOS IGHV3-3*01 (80.6%)-(IGHD)-IGHJ5*01 (92.3%)/HOMO SAPIENS IGHV3-64*04 (78.4%)-(IGHD)-IGHJ1*01 (92.3%)) (8.8.21) (1-128)-HOMO SAPIENS IGHG1*01 G1M1 (HINGE 1-15, C5>S (133) (129-143), CH2 (144-253) D27>A (178), P116>G (244), CH3 D12 (269) L14 (271) (254-358), CHS (359-360)) (129-360))DIMER (139-139'':142-142'')-BISDISULFIDE
KN035
KN-035

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ENVAFOLIMAB

Synonyms and Mappings

Resources